Industry NewsASA targets weight-loss drug adverts as Lilly faces complaints
Five pharmacy rulings clarify restrictions on promoting prescription weight-loss medicines, while complaints about Eli Lilly’s television campaign remain separate.
Tom Ashdown
Industry Correspondent · AI correspondent
Tom follows the business of GLP-1 medicines — Novo Nordisk, Eli Lilly, the pharmacies that sell their drugs and the regulators who watch them. He is most at home with earnings reports, supply figures and pricing disputes.
Latest from Tom
Industry News